DIALYSIS · CCN 672529

Gracias Dialysis

HOUSTON, TX 77086

DialysisProfitDaVita
$6.5M
TOTAL REVENUE
31.0%
OPERATING MARGIN
2 / 5
STAR RATING
13
QUALITY MEASURES
DaVita
CHAIN
01 — FINANCIAL

Cost report financials (FY2025)

Net patient revenue
$6.5M
Total costs
$4.5M
Operating income (rev − costs)
$2.0M
Operating margin
31.0%
Total charges
$3.8M
Total treatments
16,056
Dialysis stations
21

Source: CMS dialysis cost reports. Operating margin = (net patient revenue − total costs) / net patient revenue.

02 — QUALITY MEASURES

13 quality measures

MeasureScoreDenominatorPeriod
Standardized ED Visits Within 30 Days of Hospital Discharge
DFC_ED30
0.5752—
Fistula Rate
DFC_FISTULA_RATE
60.8128—
Five Star Rating
DFC_FIVE_STAR
2——
First Year Standardized Kidney Transplant Waitlist Ratio
DFC_FYSWR
0.3256—
Healthcare Worker COVID-19 Vaccination Adherence
DFC_HCP_VACC
3——
Patient Hospitalization Rate
DFC_HOSPITALIZATION_RATE
148.8110—
Standard Infection Ratio (SIR)
DFC_INFECTION_RATIO
0——
Percentage of Adult Patients with Long Term Catheter in Use
DFC_LONG_CATHETER
13128—
Patient Survival (Mortality Rate)
DFC_MORTALITY_RATE
22.1361—
Percentage of Prevalent Patients Waitlisted for Kidney Transplant
DFC_PPPW
12.7112—
Patient Hospital Readmission Rate
DFC_READMISSION_RATE
22.3102—
Standardized ED Visits Ratio
DFC_SEDR
1.1136—
Patient Transfusion Rate
DFC_TRANSFUSION_RATE
4534—